GoodRx Holdings (GDRX) Other Operating Expenses (2019 - 2026)

GoodRx Holdings has reported Other Operating Expenses for 8 years, with the latest figure at $123.0 million in Q1 2026.

• Quarterly Other Operating Expenses rose 3.52% year-over-year to $123.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $426.0 million (down 29.46% YoY) and the FY2025 annual result came in at $474.4 million, down 2.16% from the prior year.
• Other Operating Expenses improved to $123.0 million in Q1 2026 per GDRX's latest filing, from $119.2 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $306.4 million in Q4 2024 and troughed at $58.7 million in Q1 2022.
• A 5-year average of $107.1 million and a median of $109.9 million in 2023 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2025: Other Operating Expenses jumped 161.49% in 2022, then plunged 61.09% in 2025.
• Over 5 years, Other Operating Expenses stood at $69.7 million in 2022, then surged by 118.95% to $152.5 million in 2023, then jumped by 100.88% to $306.4 million in 2024, then slumped by 61.09% to $119.2 million in 2025, then gained by 3.17% to $123.0 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $123.0 million, $119.2 million, and $65.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.